Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat. Rev. Immunol. 18, 733-744 (2018)) 1 . The authors extensively discussed the role of immune cells in normal and diseased heart, specifically in myocardial infarction, myocarditis and endocarditis, heart failure and rhythm disorders 1 . Regarding rhythm disorders, they speculated that the immune immuno-cardiac electrophysiology. In fact, accumulating data indicate that the immune system can promote cardiac arrhythmias by means of autoantibodies and/or inflammatory cytokines that directly affect the function of specific ion channels on the surface of cardiomyocytes 2-4 . Several autoantibodies have been described that target cardiac Ca 2+ , K + or Na + channels and that have arrhythmogenic effects in the absence of evident histological changes in the heart; these are known as autoimmune cardiac channelopathies 2,4 . Indeed, it is well recognized that anti-Sjögren's-syndrome-related antigen A (anti-SSA) antibodies (also known as anti-Ro/SSA antibodies) can cross react with the pore region of both L-type Ca 2+ channels (Ca V 1.2 and Ca V 1.3) and T-type Ca 2+ channels (Ca V 3.1 and Ca V 3.2). By inhibiting the related Ca 2+ currents, these antibodies promote conduction disturbances, such as sinus bradycardia and atrioventricular (AV) block 5,6 ( Fig. 1a ). Similar clinical consequences were also shown for autoantibodies recognizing the extracellular loop of domain
system could contribute to arrhythmias through two mechanisms -a crosstalk between immune cells and fibroblasts and/or myocytes, leading to insulating fibrosis, or a direct participation of leukocytes (macrophages) in the electrical regulation of conducting cells, by interacting through connexin 43 (CX43)-containing gap junctions 1 .
However, the authors substantially disregarded a third important mechanism of arrhythmias in this new field of I S5-S6 of the Na V 1.5 Na + channel 7 . These antibodies, which can be detected in patients with idiopathic AV block, inhibit Na + currents and induce conduction disturbances in experimental models 7 .
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Other autoantibodies that target ion channels can affect the action potential duration (APD) of ventricular myocytes, leading to long-QT syndrome (LQTS) or short-QT syndrome (SQTS) and associated malignant arrhythmias 2 . LQTS can be induced by anti-SSA antibodies, which inhibit the rapidly activating repolarizing K + current by targeting the extracellular pore loop of the K V 11.1 K + channel (also known as hERG) 8, 9 , as well as by autoantibodies targeting K V 1.4 K + channels, possibly through blockade of the transient outward K + current 10 . Conversely, agonist-like autoantibodies targeting K V 7.1 K + channels that enhance the slowly activating repolarizing K + current were associated with SQTS 11 (Fig. 1b) .
Moreover, inflammatory cytokines -in particular, tumour necrosis factor (TNF), IL-1 and IL-6 -can be arrhythmogenic by directly affecting the function of cardiac ion channels; these are known as inflammatory cardiac channelopathies 4 . Specifically, it has been shown that TNF induces dysfunction of gap junctions in atrial myocytes through impaired expression and/or distribution of CX40 and CX43 and that these changes promote atrial fibrillation by favouring a slow and heterogeneous conduction in the atria 12 (Fig. 1c ). In addition, cytokines can favour the development of LQTS by decreasing specific cardiac K + currents and/or increasing L-type Ca 2+ currents 3, 4 . TNF inhibits transient outward, rapidly activating repolarizing and slowly activating
